Ocumetra, a leading innovator in big data-powered communication and clinical support tools, is delighted to announce the appointment of Mr. Arthur Cummings, a distinguished cataract and refractive surgeon, to its Board of Directors as Chairman. Mr. Cummings brings over three decades of unparalleled expertise in leadership, clinical practice, patient care, and clinical research to the Ocumetra team.
Arthur Cummings is internationally recognized for his contributions to eye health, specifically to refractive and cataract surgery. Throughout his career, he has held multiple leadership roles, including positions on Medical Advisory Boards (MABs), editorial boards, and governance bodies. He has received multiple international awards from the American Academy of Ophthalmology (AAO), the International Society of Refractive Surgeons (ISRS), the European Society of Cataract and Refractive Surgeons (ESCRS), to name but a few. Notably, his commitment to advancing clinical practices aligns seamlessly with Ocumetra’s mission to provide better eye health to all children globally.
“Arthur’s extensive clinical experience and leadership in the ophthalmology field are invaluable assets as we continue to advance our mission to revolutionize eyecare, with a particular focus on addressing the global myopia epidemic,” said James Loughman, CEO of Ocumetra. “His expertise will play a pivotal role in guiding our strategic initiatives and ensuring we remain at the forefront of myopia innovation. We are thrilled to have Arthur join our board.”
Arthur Cummings emphasized, “I am honoured to join the Ocumetra board and contribute to its mission of improving vision and eye health worldwide, particularly in tackling the challenges of myopia. I look forward to working with this talented team to advance innovative solutions that support children at risk of progressive myopia.”
This announcement comes at a pivotal time for Ocumetra, following its recent strategic partnership with Topcon Healthcare, Inc. Together, Ocumetra and Topcon Healthcare will continue to innovate to provide clinicians with the resources they need to more effectively support clinicians in the identification, monitoring and treatment of children at risk of progressive myopia, ensuring better eye health outcomes and improved quality of life for children globally.
About Ocumetra
Ocumetra is a global leader in myopia management, offering innovative tools and solutions to support all stakeholders in the myopia management sector. Our transformative platform empowers eye care professionals, optical groups, myopia treatment manufacturers, and diagnostic device companies to deliver clinical excellence, optimize operational efficiency, and expand market opportunities.
Our partnership approach is designed to help build successful and impactful myopia management programs, ensuring both clinical excellence and commercial success.
Our product portfolio includes:
- Clinical Decision Support Tools: Effective, streamlined patient communication, integrate refraction and axial length monitoring, and support evidence-based treatment decisions and personalized care.
- Marketing and Professional Services: Enable practices and optical groups to attract, retain, and engage patients effectively while delivering superior care.
- Data Analytics and Business Intelligence: Provide actionable insights to optimize clinical and operational outcomes.
By driving proactive myopia management adoption, Ocumetra accelerates market growth, ensures compliance with evolving standards of care, and improves outcomes for children worldwide. Learn more at Ocumetra.com.